MYD88 Leu 265 Pro (L265P) mutation, occurred in about 30% of activated B-cell-like (ABC) DLBCL, is the most common non-synonymous and gain-of-function driver mutation. The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.